Abstract | AIM OF STUDY: The primary aim of this study was to evaluate the effect of half-body irradiation (HBI) on pain and quality of life in cancer patients with multiple bone metastases. The secondary aim was to evaluate side effects of the treatment. PATIENTS AND METHODS: A total of 44 patients received lower (n = 37), upper (n = 5), or sequential HBI (n = 2). The dose for lower HBI was 8 Gy in one fraction and for upper HBI 7 Gy in one fraction, with reduction of the lung dose to 6 Gy in one fraction by partial shielding. The majority of patients (n = 41) were males with prostate cancers (93%). Outcome and side effects were measured by the EORTC Quality of Life Questionnaire C30 (QLQ-C30), and by the doctors' toxicity scores in the medical record. Pain relief was defined as a reduction of more than 10 points on the QLQ-C30 scale. Evaluations were performed before and 2, 4, 8, 16, and 24 weeks after treatment. RESULTS: Relief of pain was observed in 76% of the patients receiving HBI with 8.8% of the patients experiencing complete pain relief with no residual pain in the treated field. For most patients, the pain relief was lasting throughout the follow-up period. About one third of the patients were able to reduce their intake of analgesics. Grade 1-2 diarrhoea was the most common side effect observed in 49% of the patients two weeks after treatment. Mild pulmonary symptoms (grade 1-2) were observed in four of seven patients receiving upper HBI. No clear effect was observed on the patients' global quality of life. CONCLUSION: Single fraction HBI is safe and effective providing long lasting pain reduction in 76% of patients with multiple bone metastases.
|
Authors | Randi S Berg, Mette K Yilmaz, Morten Høyer, Nina Keldsen, Ole S Nielsen, Marianne Ewertz |
Journal | Acta oncologica (Stockholm, Sweden)
(Acta Oncol)
Vol. 48
Issue 4
Pg. 556-61
( 2009)
ISSN: 1651-226X [Electronic] England |
PMID | 18979285
(Publication Type: Clinical Trial, Phase II, Journal Article)
|
Topics |
- Aged
- Aged, 80 and over
- Bone Neoplasms
(complications, radiotherapy, secondary)
- Dose-Response Relationship, Radiation
- Female
- Follow-Up Studies
- Hemibody Irradiation
(adverse effects, methods)
- Humans
- Lung
(radiation effects)
- Male
- Middle Aged
- Pain
(etiology, prevention & control)
- Prostatic Neoplasms
(pathology)
- Quality of Life
- Surveys and Questionnaires
- Treatment Outcome
|